Panacea Biotec faces ₹4.32 crore income-tax penalty demand
As filed · Panacea Biotec Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
RegulatoryMixedLowmateriality 38 out of 100
What happened
FactPanacea Biotec received two demand orders dated September 28, 2026 from the Assistant Commissioner of Income Tax, Delhi. The orders impose aggregate penalties of approximately ₹4.32 crore for alleged misreporting or under-reporting of income for assessment years 2022-23 and 2023-24.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
Scale
- 1.0% of FY26 revenue
₹4.32 Cr stated in the filing against ₹413.49 Cr revenue (FY26, standalone)
Source: financial_facts · exchange_table
Watch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
Evidence
How CapitSignal classified this
- Reasoning:
- The demand creates a potential tax liability, though the company considers it not maintainable and intends to appeal. Panacea Biotec states that it does not foresee a significant financial, operational or other impact.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%